Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
10,000+ US Securities
Unlisted Companies not available on US Stock Exchanges
Professionally managed portfolios, designed by Vested’s research team
Get exposure to 50+ countries via global funds managed by the world’s top fund managers
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology. more
| Time Frame | FXH | S&P500 |
|---|---|---|
| 1-Week Return | 0.12% | 1.47% |
| 1-Month Return | -0.34% | 6.9% |
| 3-Month Return | -1.03% | 8.67% |
| 6-Month Return | 1.7% | 10.45% |
| 1-Year Return | 13.36% | 26.35% |
| 3-Year Return | 6.09% | 79.84% |
| 5-Year Return | 0.37% | 78.2% |
| 10-Year Return | 97.46% | 259.86% |
| Time Frame | FXH | S&P500 |
|---|---|---|
| 1-Week Return | 6.45% | 114.02% |
| 1-Month Return | -4.06% | 125.20% |
| 3-Month Return | -4.11% | 40.10% |
| 6-Month Return | 3.48% | 22.33% |
| 1-Year Return | 13.36% | 26.35% |
| 3-Year Return | 1.99% | 21.61% |
| 5-Year Return | 0.07% | 12.25% |
| 10-Year Return | 7.04% | 13.66% |
| Stock name | Ticker | Weight |
|---|---|---|
Organon & Co. | OGN | 3.85% |
Humana Inc. | HUM | 2.98% |
Elevance Health Inc. | ELV | 2.72% |
Molina Healthcare, Inc. | MOH | 2.49% |
Solventum Corporation | SOLV | 2.29% |
Globus Medical, Inc. (Class A) | GMED | 2.26% |
Exelixis, Inc. | EXEL | 2.24% |
Incyte Corporation | INCY | 2.24% |
The Cigna Group | CI | 2.23% |
Biogen Inc. | BIIB | 2.23% |
DaVita Inc. | DVA | 2.21% |
Cardinal Health, Inc. | CAH | 2.01% |
Universal Health Services, Inc. (Class B) | UHS | 2% |
Bio-Rad Laboratories, Inc. (Class A) | BIO | 1.99% |
Zimmer Biomet Holdings, Inc. | ZBH | 1.98% |
Regeneron Pharmaceuticals, Inc. | REGN | 1.96% |
HCA Healthcare, Inc. | HCA | 1.96% |
Chemed Corporation | CHE | 1.96% |
Encompass Health Corporation | EHC | 1.88% |
Masimo Corporation | MASI | 1.74% |
Ionis Pharmaceuticals, Inc. | IONS | 1.73% |
Tenet Healthcare Corporation | THC | 1.71% |
Penumbra, Inc. | PEN | 1.71% |
United Therapeutics Corporation | UTHR | 1.67% |
Pfizer Inc. | PFE | 1.63% |
Merck & Co., Inc. | MRK | 1.63% |
Amgen Inc. | AMGN | 1.62% |
Becton, Dickinson and Company | BDX | 1.58% |
Insmed Incorporated | INSM | 1.47% |
QIAGEN N.V. | QGEN | 1.47% |
Illumina, Inc. | ILMN | 1.46% |
Certara, Inc. | CERT | 1.41% |
Revvity, Inc. | RVTY | 1.37% |
Natera, Inc. | NTRA | 1.34% |
Henry Schein, Inc. | HSIC | 1.31% |
Sarepta Therapeutics, Inc. | SRPT | 1.3% |
Quest Diagnostics Incorporated | DGX | 1.26% |
Labcorp Holdings Inc. | LH | 1.25% |
Steris Plc | STE | 1.25% |
Gilead Sciences, Inc. | GILD | 1.24% |
Bristol-Myers Squibb Company | BMY | 1.22% |
ResMed Inc. | RMD | 1.2% |
Medtronic Plc | MDT | 1.16% |
UnitedHealth Group Incorporated | UNH | 1.16% |
GE HealthCare Technologies Inc. | GEHC | 1.11% |
The Cooper Companies, Inc. | COO | 1.11% |
Waters Corporation | WAT | 0.99% |
Eli Lilly and Company | LLY | 0.93% |
IQVIA Holdings Inc. | IQV | 0.89% |
Agilent Technologies, Inc. | A | 0.89% |
Neurocrine Biosciences, Inc. | NBIX | 0.89% |
Halozyme Therapeutics, Inc. | HALO | 0.88% |
Medline Inc. (Class A) | MDLN | 0.88% |
Align Technology, Inc. | ALGN | 0.85% |
Zoetis Inc. | ZTS | 0.82% |
Thermo Fisher Scientific Inc. | TMO | 0.82% |
BioMarin Pharmaceutical Inc. | BMRN | 0.81% |
Johnson & Johnson | JNJ | 0.8% |
Medpace Holdings, Inc. | MEDP | 0.78% |
Abbott Laboratories | ABT | 0.73% |
West Pharmaceutical Services, Inc. | WST | 0.5% |
Sotera Health Company | SHC | 0.43% |
Royalty Pharma Plc (Class A) | RPRX | 0.43% |
Edwards Lifesciences Corporation | EW | 0.42% |
Envista Holdings Corporation | NVST | 0.42% |
IDEXX Laboratories, Inc. | IDXX | 0.41% |
Intuitive Surgical, Inc. | ISRG | 0.4% |
Veeva Systems Inc. (Class A) | VEEV | 0.4% |
Viking Therapeutics, Inc. | VKTX | 0.39% |
Vertex Pharmaceuticals Incorporated | VRTX | 0.39% |
DexCom, Inc. | DXCM | 0.38% |
AbbVie Inc. | ABBV | 0.38% |
Danaher Corporation | DHR | 0.37% |
Alnylam Pharmaceuticals, Inc. | ALNY | 0.37% |
Stryker Corporation | SYK | 0.36% |
Boston Scientific Corporation | BSX | 0.36% |
US Dollar | .USD | 0.03% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
First Trust Health Care AlphaDEX® Fund (FXH) share price today is $113.62.
Yes, Indians can buy shares of First Trust Health Care AlphaDEX® Fund (FXH) on Vested. To buy FXH from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of First Trust Health Care AlphaDEX® Fund (FXH) on Vested. You can start investing in First Trust Health Care AlphaDEX® Fund (FXH) with a minimum investment of $1.
The 52-week high price of First Trust Health Care AlphaDEX® Fund (FXH) is $120.13. The 52-week low price of First Trust Health Care AlphaDEX® Fund (FXH) is $96.71.
The stock symbol (or ticker) of First Trust Health Care AlphaDEX® Fund is FXH.
Yes, you can setup SIP in First Trust Health Care AlphaDEX® Fund shares. Follow the below steps to create the SIP:
Here is the historical performance of FXH on the Vested app.
The expense ratio of First Trust Health Care AlphaDEX® Fund (FXH) is 0.62%.
Link copied